These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9040528)

  • 1. Relationships between symptoms of schizophrenia and substance abuse.
    Brunette MF; Mueser KT; Xie H; Drake RE
    J Nerv Ment Dis; 1997 Jan; 185(1):13-20. PubMed ID: 9040528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
    Kim JH; Kim D; Park SH; Lee HB; Chung EK
    J Nerv Ment Dis; 2007 Jul; 195(7):622-4. PubMed ID: 17632255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Courses of substance use and schizophrenia in the dual-diagnosis patients: is there a relationship?
    Goswami S; Singh G; Mattoo SK; Basu D
    Indian J Med Sci; 2003 Aug; 57(8):338-46. PubMed ID: 12944690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperament and substance abuse in schizophrenia: is there a relationship?
    Van Ammers EC; Sellman JD; Mulder RT
    J Nerv Ment Dis; 1997 May; 185(5):283-8. PubMed ID: 9171804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?
    Dervaux A; Baylé FJ; Laqueille X; Bourdel MC; Le Borgne MH; Olié JP; Krebs MO
    Am J Psychiatry; 2001 Mar; 158(3):492-4. PubMed ID: 11229997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
    Kirkpatrick B; Amador XF; Flaum M; Yale SA; Gorman JM; Carpenter WT; Tohen M; McGlashan T
    Schizophr Res; 1996 May; 20(1-2):69-77. PubMed ID: 8794495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis and schizophrenia: results of a follow-up study.
    Caspari D
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(1):45-9. PubMed ID: 10195343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
    Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
    Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study.
    Cuffel BJ; Chase P
    J Nerv Ment Dis; 1994 Jun; 182(6):342-8. PubMed ID: 8201306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using measures of readiness to change in individuals with schizophrenia.
    Addington J; el-Guebaly N; Duchak V; Hodgins D
    Am J Drug Alcohol Abuse; 1999 Feb; 25(1):151-61. PubMed ID: 10078983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia and substance abuse: prevalence issues.
    el-Guebaly N; Hodgins DC
    Can J Psychiatry; 1992 Dec; 37(10):704-10. PubMed ID: 1473076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of patterns of substance abuse among patients with schizophrenia.
    Cuffel BJ; Heithoff KA; Lawson W
    Hosp Community Psychiatry; 1993 Mar; 44(3):247-51. PubMed ID: 8444435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia.
    Mueser KT; Drake RE; Ackerson TH; Alterman AI; Miles KM; Noordsy DL
    J Abnorm Psychol; 1997 Aug; 106(3):473-7. PubMed ID: 9241949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of substance abuse in schizophrenia: nature and significance.
    DeQuardo JR; Carpenter CF; Tandon R
    J Psychiatr Res; 1994; 28(3):267-75. PubMed ID: 7932286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.